Fluconazole vs. amphotericin B for the management of candidaemia in adults: A meta-analysis

Mycoses

Volumn 44, Issue 5-6, 2001, Pages 125-135

  Kontoyiannis, D P ^a   Bodey, G P ^a   Mantzoros, C S ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amphotericin B; Antimycotic chemotherapy; Candidaemia; Fluconazole; Meta analysis; Prospective studies

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE;

ADULT; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FUNGEMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT FAILURE;

ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CLINICAL TRIALS; FLUCONAZOLE; FUNGEMIA; HUMANS; ODDS RATIO; TREATMENT FAILURE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 0034947930     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2001.00649.x     Document Type: Review

References (50)

1. Wey, S. B., Mori, M., Pfaller, M. A., Woolson, R. F. & Wenzel, R. P. (1988) Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch. Intern. Med. 148, 2642-2645.
2. Wenzel, R. P. (1995) Nosocomial candidemia: risk factors and attributable mortality. Clin. Infect. Dis. 20, 1531-1534.
3. Edwards, J. E., Bodey, G. P., Bowden, R. A., et al. (1997) International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin. Infect. Dis. 25, 43-59.
4. Gallis, H. A., Drew, R. H. & Pickard, W. W. (1990) Amphotcricin B: 30 years of experience. Rev. Inject. Dis. 12. 308-329.
5. Bodey, G. P. (1992) Azole antifungal agents. Clin. Infect. Dis. 14 (Suppl. 1), S161-S169.
6. Rex, J. H., Bennett, J. E., Sugar, A. M., et al. (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the-National Institute. N. Engl. J. Med. 331, 1325-1330.
7. Meunier, F. (1994) Management of candidemia (editorial). N. Engl. J. Med. 331, 1371-1372.
8. Pfaller, M. A. (1996) Nosocomial candidiasis: emerging species, reservoirs and modes of transmission. Clin. Infect. Dis. 22 (Suppl. 2), S89-S94.
9. Rex, J. H. (1996) Editorial response. Catheters and candidemia. Clin. Infect. Dis. 22, 467-470.
10. Badgett, R. G., O'Keefe, M. & Henderson, M. C. (1997) Using systematic reviews in clinical education. Ann. Intern. Med. 126, 886-890.
11. Lau, J., Ioannidis, J. A. & Schmid, C. H. (1997) Quantitative synthesis in systemic reviews. Ann. Intern. Med. 127, 820-826.
12. Counsell, C. (1997) Formulating questions and locating primary studies for inclusion in systematic reviews. Ann. Intern. Med. 127, 380-387.
13. Meade, M. O. & Richarsdon, S. W. (1997) Selecting and appraising studies for a systematic review. Ann. Intern. Med. 127, 531-537.
14. Mulrow, C., Langhorne, P. & Grimshaw, J. (1997) Intergrating heterogeneous pieces of evidence in systematic reviews. Ann. Intern. Med. 127, 989-995.
15. DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Control. Clin. Trials 7, 177-188.
16. Knaus, W. A., Draper, E. A. & Wagner, D. P. (1985) APACHE II: a severity of disease classification system. Crit. Care. Med. 13, 818-829.
17. LeGall, J. R., Loirat, P., Alperovitch, A., Glaser, P., Cranthil, C. & Mathieu, D. (1984) A simplified acute physiology score for ICU patients. Crit. Care Med. 12, 975-977.
18. Anaissie, E.J., Darouiche, R. O., Abi-Said, D., et al. (1996) Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotcricin B and review of the literature. Clin. Infect. Dis. 23, 964-972.
19. Nguyen, H. M., Peacock, J. E., Tanner, D. C., et al. (1995) Therapeutic approaches in patients with candidemia. Arch. Intern. Med. 155, 2429-2435.
20. Driessen, M., Ellis, J. B., Cooper, P. A., et al. (1996) Fluconazole versus amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Fed. Infect. Dis. J. 15, 1107-1112.
21. Ellis, M. E., Halim, M. A., Spence, D., et al. (1995) Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever-preliminary observation from a pilot, exploratory study. J. Infect. Dis. 30, 141-146.
22. Abele-Horn, M., Kopp, A., Sternberg, U., et al. (1996) A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. Infection 24, 426-432.
23. LaPierre, V., Marie, J. P. & Pico, J. L. (1992) Intravenous fluconazole versus intravenous amphotericin B in the management of febrile neutropenic patients: a multicentric randomized study. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC: American Society of Microbiology, abstract 624.
24. Viscoli, C., Castagnola, E., Van Lint, M. T., et al. (1996) Fluconazole versus amphotericin B as empirical therapy for unexplained fever in granulocytopenic cancer patients: a pragmatic, multicenter. prospective and randomized clinical trial. Eur. J. Cancer 32, 814-820.
25. Anaissie, E. J., Vartivarian, S. E., Abi-Said, D., et al. (1996) Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am. J. Med. 101, 170-176.
26. Nolla-Salas, J., Sitges-Serra. A., Leon-Gil, C., Martinez-Gonzalez, J., Leon-Regidor, M. A. & Ibanez-Lucia, P. (1997) Study group of fungal infection in the ICU. Intensive Care Med. 23, 23-30.
27. Phillips, P., Shafran, S., Garber, G., et al. (1997) Multicenter randomized trial of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group. Eur. J. Clin. Microbiol. Infect. Dis. 16, 337-345.
28. Kujath, P., Lerch, K., Kochendorfer, P. & Boos, C. (1993) Comparative study of the efficacy of fluconazole versus amphotericin B/flucytocine in surgical patients with systemic mycoses. Infection 21, 376-382.
29. Medoff, G., Dismukes, W. E., Pappagianis, D., Diamond, R., Gallis, H. A. & Drutz, D. (1992) General guidelines for the evaluation of new antifungal drugs for the treatment of systemic fungal infections. Clin. Infect. Dis. 15 (Suppl. 1), S274-S281.
30. Rex, J. H., Pfaller, M. A., Barry, A. L., Nelson, P. W. & Webb, C. D. (1995) Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrob. Agents Chemother. 39, 40-44.
31. Blinkhorn, R. J., Adelstein, D. & Spagnuolo, P. J. (1989) Emergence of a new opportunistic pathogen, Candida lusitaniae. J. Clin. Microbiol. 27, 236-240.
32. Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G. & Dunagan, W. C. (1992) Candidemia in a tertiary care hospital: epidemiology, risk-factors, and predictors of mortality. Clin. Infect. Dis. 15, 414-421.
33. Georgopapadakou, N. & Walsh, T. J. (1996) Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemother. 40, 279-291.
34. Graybill, J. R. (1997) Editorial response. Can we agree on the treatment of candidiasis? Clin. Infect. Dis. 25, 60-62.
35. Uzun, O. & Anaissie, E. J. (1996) Problems and controversies in the management of hematogenous candidiasis. Clin. Infect. Dis. 22 (Suppl. 2), S95-S101.
36. Eubanks, P. J., de Virgilio, C. & Klein, S. (1993) Candida sepsis in surgical patients. Am. J. Surg. 166, 617-620.
37. Van't Wout, J. W., Mattie, H. & van Furth, R. (1988) A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections. J. Antimicrob. Chemother. 21, 665-672.
38. Kujath, P. & Lerch, K. (1989) Secondary mycosis in surgery: treatment with fluconazole. Infection 17, 111-117.
39. Nolla-Salas, J., Leon, C., Torres-Rodriquez, J. M., Martin, E. & Sitges-Serra, A. (1992) Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clin. Infect. Dis. 14, 952-954.
40. Graninger, W., Presteril, E., Schneeweis, B., Teleky, B. & Georgopoulos, A. (1993) Treatment of Candida albicans fungemia with fluconazole. J. Infect. Dis. 26, 133-146.
41. Ikemoto, H. (1989) A clinical study of fluconazole for the treatment of deep mycoses. Diagn. Microbiol. Infect. Dis. 12 (Suppl. 4), S239-S247.
42. Komshian, S. V., Uwaydah, A. K., Sobel, J. D. & Crane, L. R. (1989) Fungemia caused by Candida species and Torulopsis grabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 11, 379-390.
43. Miller, P. J. & Wenzel, R. P. (1987) Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J. Infect. Dis. 156, 471-477.
44. Harvey RI, Myers, J. P. (1987) Nosocomial fungemia in a large community teaching hospital. Arch. Intern. Med. 147, 2117-2120.
45. van't Wout, J. W. (1996) Fluconazole treatment of candidal infections caused by non-albicans Candida species. Eur. J. Microbiol. Infect. Dis. 15, 238-242.
46. Wingard, J. R. Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E. & Saral, R. (1993) Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob. Agents. Chemother. 37, 1847-1849.
47. Abi-Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H. & Vartivarian, S. (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24, 1122-1128.
48. Rex, J. H., Pfaller, M. A., Galgiani, J. N., et al. (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, intraconazole and Candida infections. Clin. Infect. Dis. 24, 235-247.
49. Bodey, G. P. (1993) Hematogenous and major organ candidiasis. In: Bodey. G. P. (ed.) Candidiasis: Pathogenesis, Diagnosis and Treatment. New York: Raven Press, pp. 279-329.
50. Antman, E. M., Lau, J., Kupelnick, B., Mosteller, F. & Ghalmers, T. G. (1992) A comparison of results of meta-analyscs of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction. J. Am. Med. Assoc. 268, 240-248.